✕

Download the Practo app for free

Get Rs. 200 HealthCash
Download the app now
✔ Book instant appointments 24x7
✔ Bookmark doctors for quick access
✔ Consult online with a doctor in 60s
✕
Free ₹200 worth HealthCash on app
Use HealthCash to order medicines, health products & much more
Get App

Cereloid Tablet

Manufactured bySUN PHARMA LABORATORIES LTD
ContainsCo-Dergocrine Mesylate
CURRENTLY UNAVAILABLE

Description

Cereloid Tablet is an ergot alkaloid, which is used to relieve the signs and symptoms of age-related cognitive impairment in patients with dementia related to aging or associated with Alzheimer's disease, a condition in which the patient's memory and ability to think, communicate, learn, and handle daily activities are impaired slowly. This medicine is not recommended for use in children.
QUICK LINKS:
Side effectsConcernsUsage

How will this medicine affect me?

Consult top doctors online and get an answer now.
Consult now

Looking for a doctor?

Book an appointment with the top doctors near you
Book now

Should you be taking this medicine?

Consult with a Doctor for the best diagnosis.

Looking for a doctor?

Book an appointment with the top doctors near you

Substitutes

List of substitutes for Cereloid Tablet

Side effects

Major & minor side effects for Cereloid Tablet

Dizziness

Lightheadedness

Drowsiness

Skin rash

Slow heart rate

Blurred vision

Flushing

Loss of appetite

Nausea and Vomiting

Stomach cramps

Stuffy nose

Fainting

Uses of Cereloid Tablet

What is it prescribed for?

Dementia

This medicine is used to improve the cognitive function in patients with declined mental capacity or symptoms of dementia related to aging or associated with Alzheimer's disease.
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?

    The effect of this medicine can be observed within 3 to 4 weeks of administration of the dose.

  • How long do the effects of this medicine last?

    The amount of time for which this medicine remains active in the body is not clinically established.

  • Is it safe to consume alcohol while taking this medicine?

    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

  • Is this a habit forming medicine?

    No habit-forming tendencies were reported.

  • Can this medicine be taken during pregnancy?

    This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking/receiving this medicine.

  • Can this medicine be taken while breast-feeding?

    This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before taking/receiving this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to Co-Dergocrine Mesylate or any other components present along with it.

Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking/receiving this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before taking/receiving this medicine.

General warnings

Kidney impairment

This medicine should be used with caution in patients suffering from kidney diseases due to the increased risk of adverse effects. Close monitoring of kidney function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Liver impairment

This medicine should be used with extreme caution in patients suffering from liver impairment due to the increased risk of severe adverse effects. Close monitoring of liver function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Use in elderly population

This medicine should be used with extreme caution in the elderly population due to the increased risk of severe adverse effects. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Use in children

This medicine is not recommended for use in patients below 18 years of age since the safety and efficacy of use are not clinically established.

Driving or operating machinery

This medicine may cause dizziness, blurred vision, or drowsiness in some patients. It is advised that you do not perform any activities that require high mental alertness like driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Other medicines

Cereloid Tablet may interact with many other medicines and may cause severe adverse effects. Hence, it is advised that you inform the doctor about all your current medicines including any herbs and supplements before beginning treatment with this medicine.

Missed Dose

Oral form: Take the missed dose as soon as you remember. If it is almost the time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose. Injection: Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of a missed dose is very low.

Overdose

Oral form: Seek emergency medical treatment or contact the doctor in case of an overdose. Injection: Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of an overdose is very low. However, emergency medical treatment will be instituted by the doctor if an overdose is suspected.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.

Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Interaction with Medicine

Disease interactions

Psychosis

This medicine is not recommended for use in patients with acute or chronic psychosis due to the risk of worsening of the patient's condition. An alternative treatment option should be considered based on the clinical condition.

Cardiovascular diseases

This medicine should be used with extreme caution in patients with severe cardiovascular diseases due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition.

Food interactions

Information not available.

Lab interactions

Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Oral form: Take this medicine exactly advised by your doctor. Do not take in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable effects. Do not stop taking this medicine before completion of the course/without consulting your doctor. Injection: This medicine is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. Follow all the instructions given by your doctor. Inform the doctor if you have a known allergy to this medicine. Report all your current medicines as well as your medical conditions to the doctor before receiving this medicine.

Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Causes sleepiness

How it works

This medicine decreases the abnormal activity in the brain and helps in improving the symptoms of declined mental capacity.

Legal Status

Approved

Unknown

Unknown

Unknown

Classification

Category

Ergoloid Derivatives, Miscellaneous central nervous system agents

Schedule

Schedule H

Ergoloid mesylate - DrugBank [Internet]. Drugbank.ca. 2018 [cited 24 December 2018]. Available from:

https://www.drugbank.ca/drugs/DB01049

Ergoloid Mesylates [Internet]. Pubchem.ncbi.nlm.nih.gov. 2018 [cited 24 December 2018]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/592735

ErgoloMesylates: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2018 [cited 24 December 2018]. Available from:

https://medlineplus.gov/druginfo/meds/a682097.html

Related Questions

Something doesn’t feel right?
Report an error

Information on this page was last updated on 23 May 2019

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.